CDRE — Cadre Holdings, Inc.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1860543 ·
Last close
$30.83
Market Cap
$1.32B
52W High
$34.12
52W Low
$25.65
ADV30
393,073
Next earnings
2026-08-05
Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally. It operates through two segments, Product and Distribution. The company offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. It also provides third-party products, such as uniforms, optics, boots, firearms, and ammunition. In addition, the company designs, manufactures and services equipment, vessels, precision components and remote handling systems for the nuclear, defence, and oil and gas industries. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies, including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, and various foreign government agencies. The company sells its products through its direct sales force, distribution channels and distribution partners/agents, online stores, and third-party resellers. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 155,429,000 60,166,000 9,333,000 1,975,000 879,736,000 41,272,000 543,620,000
Dec 2025 167,224,000 72,623,000 21,896,000 11,739,000 770,031,000 122,898,000 452,227,000
Sep 2025 155,869,000 66,625,000 20,890,000 10,941,000 792,055,000 150,875,000 451,681,000
Jun 2025 157,109,000 64,249,000 18,011,000 12,211,000 794,437,000 137,469,000 461,977,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$68,835,000
Investing CF
$-251,293,000
Financing CF
$92,290,000
CapEx
$-8,227,000
Dividends Paid
$-15,871,000
Buybacks
EPS Diluted TTM
$0.89
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$32,463,000
Inventory
$130,989,000
Receivables
$111,292,000
ST Investments
EBIT TTM
$67,069,000
Pretax Income TTM
$52,549,000
Interest Exp TTM
$14,520,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$635,630,976
EBITDA
$97,490,000
Free Cash Flow
$23,675,624
Enterprise Value
$1,666,957,440
Total Cash
$42,185,000
Total Debt
$389,696,992
Shares Out
42,797,451
Trailing EPS
$0.84
Book Value
$7.85
ROE
11.3%
ROA
6.3%
Div Yield
1.28%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 610,308,000 75,047,000 44,139,000 770,031,000 452,227,000 63,705,000
Dec 2024 567,561,000 72,768,000 36,133,000 652,713,000 341,198,000 31,777,000
Dec 2023 482,532,000 58,711,000 38,641,000 431,179,000 234,017,000 73,209,000
Dec 2022 457,837,000 21,071,000 5,820,000 391,952,000 226,062,000 46,409,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$1.58

Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $20.00 · spot: $30.83 · call volume: 133 · put volume: 16
Expected Move to 2026-10-16: ±$7.38 (23.92%) — implied range $23.45$38.20 · ATM straddle on $30.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TNDM TANDEM DIABETES CARE INC $1.34B $19.50
AORT ARTIVION, INC. $1.30B $26.83
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. $1.34B $22.83
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.29B $16.65
CNMD CONMED Corp $1.39B $46.30

News headlines (Yahoo Finance, 1h cache)

ADT (ADT) Tops Q2 Earnings and Revenue Estimates
2026-07-30 12:35 · Yahoo
1 Cash-Producing Stock to Consider Right Now and 2 We Brush Off
2026-07-27 13:01 · Yahoo
Here Are Monday’s Top Wall Street Analyst Research Calls: Alphabet, Clean Harbors, Ford, Huntington Bancshares, Rivian, Rocket Lab, Terawulf, Vale, Warner Bros. Discovery, and More
2026-07-27 11:46 · Yahoo
Cadre Holdings (CDRE) Affirms Dividend, Is It Still 34% Undervalued?
2026-07-27 02:08 · Yahoo
Cadre Holdings Announces Second Quarter 2026 Earnings and Conference Call Information
2026-07-23 20:45 · Yahoo
Cadre Holdings Declares Quarterly Dividend of $0.10 Per Share
2026-07-21 20:15 · Yahoo
1 Small-Cap Stock Worth Investigating and 2 That Underwhelm
2026-07-17 14:41 · Yahoo
Cadre Holdings’ (CDRE) Safariland Selected for FBI Ballistic Panel Contract
2026-07-10 13:59 · Yahoo
Aerospace and Defense Stocks Q1 In Review: Cadre (NYSE:CDRE) Vs Peers
2026-07-06 17:32 · Yahoo
Cadre Holdings CEO and Chairman Sells 75,000 Shares. Should You Sell CDRE Too?
2026-07-01 18:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.